Literature DB >> 6973559

HLA-linked B cell alloantigens of a new segregant series: population and family studies of the SB antigens.

S Shaw, M S Pollack, S M Payne, A H Johnson.   

Abstract

In order to define the new human histocompatibility antigens, we have generalized primed lymphocytes using responder and stimulator cells matched for all recognized HLA-linked histocompatibility antigens (A,B,C,D,DR,MB). Many such primed lymphocytes give highly discriminatory proliferative responses specific for antigens which differ between HLA-A,B,C,D,DR, and MB matched restimulating cells. Five distinct antigens have been defined which appear to be part of a single segregant series (designated "SB"). Studies in a DR/GLO recombinant family indicate that the antigens are coded by an HLA-linked gene telomeric to GLO. Family studies of 57 HLA haplotypes provide an estimate of genotype frequency which is 12% or less for four of the SB alleles but approximately 50% for the most common (SB4, which may be a "public: determinant); approximately 25% of haplotypes are blank. Population studies of one of the SB antigens (SB1) suggest that it is in linkage disequilibrium with the SB antigens are part of a highly polymorphic new segregant series of B cell alloantigens encoded by a gene that maps between HLA-B and GLO.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6973559     DOI: 10.1016/0198-8859(80)90104-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  16 in total

1.  The genomic organisation and nucleotide sequence of the HLA-SB(DP) alpha gene.

Authors:  S K Lawrance; H K Das; J Pan; S M Weissman
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

2.  Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.

Authors:  S Rosen-Bronson; A H Johnson; R J Hartzman; D D Eckels
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Restriction fragment length polymorphism of the HLA-DP subregion and correlations to HLA-DP phenotypes.

Authors:  J J Hyldig-Nielsen; N Morling; N Odum; L P Ryder; P Platz; B Jakobsen; A Svejgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

4.  Peptide-mediated modulation of T-cell allorecognition.

Authors:  D D Eckels; J Gorski; J Rothbard; J R Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  The canine major histocompatibility complex. Supertypic specificities defined by the primed lymphocyte test (PLT).

Authors:  W C Ladiges; R F Raff; S Brown; H J Deeg; R Storb
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.

Authors:  D D Eckels; R J Hartzman
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cells.

Authors:  G Pawelec; S Shaw; M Schneider; A Rehbein; P Wernet
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man: poly(L-phenylalanine, L-glutamic acid)-poly (DL-alanine)--poly(L-lysine) and L-glutamic acid, L-alanine, L-tyrosine (60:30:10).

Authors:  M M Chan; W B Bias; S H Hsu; D A Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus.

Authors:  N A Bishof; T R Welch; L S Beischel; D Carson; P A Donnelly
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

10.  Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.

Authors:  Y Matsui; S M Alosco; Z Awdeh; R J Duquesnoy; P L Page; R J Hartzman; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.